he obesity epidemic is a global public health concern that threatens to reduce life expectancy around the world. 1,2 Excess weight, particularly abdominal obesity, causes or exacerbates cardiovascular and metabolic risk factors, including hypertension, dyslipidemia, and type 2 diabetes mellitus (T2DM). [3][4][5] These risk factors synergistically increase the likelihood of morbidity and mortality of cardiovascular disease (CVD), 6,7 which leads to rising healthcare costs. 8 Actions promoting health check-ups for obesity-related conditions and prevention strategies have been proposed; 9 however, the theoretical background has not been fully coordinated, and, most importantly, the actions to reduce abdominal adiposity has not been fully validated in terms of global cardiovascular risk management. The contribution of abdominal obesity to global cardiometabolic risk will be reviewed and the potential, underlying mechanisms and management strategy will be also discussed.
Contribution of Abdominal Obesity to CVDRecent studies show that waist circumference is directly related to all-cause mortality when adjusted for body mass index (BMI), 6 and is also strongly associated with the mortality and morbidity of CVD. 7 The facts highlight the importance of visceral fat over subcutaneous fat deposits and promote the incorporation of waist circumference into the diagnosis of metabolic syndrome (MetS). 3-5 Each entity of CVD will be discussed below.
Coronary Heart Disease (CHD)In the landmark INTERHEART study, 10 Yusuf et al reported the effect of various measures of adiposity on rates of acute myocardial infarction (AMI) by comparing 12,461 AMI cases and 14,637 standardized controls of varying ethnicity from 52 countries. BMI showed a modest association with AMI (unadjusted odds ratio (OR) 1.44 for 1 st vs 5 th quintile), but this association was lost after adjustment for other risk factors. Meanwhile, the adjusted OR for quintile of the waist-to-hip ratio was successively greater than that of the previous one (OR 1.15, 1.39, 1.90, and 2.52, respectively). Waist-to-hip ratio, and the waist and hip circumferences were highly associated with the risk of AMI, even after adjustment for other risk factors (OR for 1 st vs 5 th quintiles, 1.75, 1.33, and 0.76, respectively; P<0.0001). More recently, investigators in the EPIC-Norfolk study reported that waist circumference, but not BMI, was a significant estimate for all CHD events during 9.1 years and that hip circumference appeared to protect against CHD. 11 Taken together, a redefinition of obesity based on waist circumference, instead of BMI, is a better estimate of CHD in most ethnic groups, and the notion can be supported that abdominal adiposity, not subcutaneous adiposity, is closely linked to the onset of CHD. The presence of MetS appears to be associated with worse outcomes in patients with AMI 12 or in patients following coronary artery bypass surgery. 13 In subjects with angiographically normal coronary arteries, acetylcholine-induced coronary vasoconstriction correlated ...